atropinelow-dose atropinemyopia
… 0.01% low-dose atropine for 24 months (0.01%) or 0.1% low-dose atropine for 6 months, then 0.01% for 18 months (0.1% loading dose) or p…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,261–1,320 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
patisiran3pulmonary vasodilators3sulfamethoxazole/trimethoprim3terbinafine3teriflunomide3zoledronate33,4-methylenedioxymethamphetamine3AFP3Amoxicillin–clavulanic acid3Anticancer drugs3Avibactam3Bicarbonate3CCL193CFTR modulators3CTLA-43Cardiovascular drugs3DMSO3Dimethyl fumarate3Domperidone3Dual antiplatelets3Folinic acid3GDF153GM-CSF3Hexavalent chromium (Cr(VI))3Human albumin3Hypochlorous acid3IPACK3IV antibiotics3IVT3Immune checkpoint inhibitors (ICIs)3Janus kinase (JAK) inhibitors3Janus kinase inhibitor3Low-dose atropine3Neurogastroenterol Motil3Oncovin3P2Y123Pharmacotherapies3Psychedelics3STS3Tazobactam3Tigecycline3Tolvaptan3VIA3Vaccine3Vascular endothelial growth factor inhibitors3Vitamin E3Vusolimogene oderparepvec3Yttrium-903Zoledronic acid3abacavir3acenocoumarol3alpha blockers3angiotensin receptor blocker3angiotensin receptor-neprilysin inhibitors3antacids3antiarrhythmic drugs3anticoagulation3antidiabetics3antiepileptics3antiplatelet3
Articles mentioning drugs
10,506 articles · page 472 of 876ursodeoxycholic acidcholic acidBile acid synthetic defectsliver transplantation
… a serum bile acid level obtained when the patient is receiving ursodeoxycholic acid because elevated serum bile acids may not necessarily exclude a…
proton pump inhibitorNutri Peptisob Energybroad spectrum antibioticspancreatitisnasogastric decompressiondiabetes
…mpression, broad spectrum antibiotics, intravenous fluids and a proton pump inhibitor. In view of persistent large gastric aspirates, Polymeric feeds…
inhaled prostacyclinoral phosphodiesterase inhibitororal endothelin receptor antagonistHepatopulmonary syndromePortopulmonary hypertensionportal hypertensionperoxisomal biogenesis disorderPoPHveno-occlusive disease
…hodiesterase inhibitor, oral endothelin receptor antagonist and inhaled prostacyclin). Currently, she is being consider for portosystemic shunt clos…
loperamideMaralixibatileal bile acid transporter (IBAT) inhibitorsByler diseaseArch Pathol Lab Medliver transplantationSurgical biliary diversion
…edure.The frequency of bowel movements decreased as well as the loperamide dose. Liver histology showed a reduction in hepatic steatosis f…
aminosalicylatesthiopurinesbiologicsInflammatory bowel diseaseulcerative colitisCrohn’s diseaseIBDIBD-unclassified
…e colitis. 34/50 (68%) were on thiopurines, 31/50 (62%) were on aminosalicylates and 19/50 (38%) were on biologics. 2/50 (4%) were on no mainten…
hydrocortisoneprednisoloneinflammatory bowel diseaseadrenal insufficiencyIBDIBD-Uulcerative colitis
…s. CD n=2IBD-U n=2UC n=2 A1a n=4A1b n=2 Adrenal Sufficient 2 IV hydrocortisone/oral prednisolone 25–30.7 2–3 Weakness, dizziness, low energy, …
N-acetylcysteineacetaminophenparacetamoldiabetesCOVID-19diabetic ketoacidosis
…d ventilation. ALF management protocol was initiated, including N-acetylcysteine. On day 4, Patients B and C developed cardiovascular instabilit…
phytomenadionealpha tocopherylcystic fibrosisbiliary atresiacholangitisRCPCH Publications
… units vitamin A, 600 units vitamin D, 40 mg vitamin E and 2 mg phytomenadione in 0.1 mL in an MCT oil base (Paravit CF®).The aim of this stud…
94.3%
beta blockerslipid-lowering drugsACE inhibitors/angiotensin receptor blockersacute myocardial infarctionLombardy Health Databasedual antiplatelet therapypostdischarge therapypostdischarge therapyAMI
…s 63%; ACE inhibitors/angiotensin receptor blockers 60% vs 64%; beta blockers 53% vs 61%; lipid-lowering drugs 45% vs 58%; p<0.0001 for all d…
SGLT2 inhibitorsangiotensin receptor-neprilysin inhibitorsmineralocorticoid receptor antagonistsHFpEFheart failureHeart failure with preserved ejection fraction (HFpEF)
…erences showed both regional similarities and differences, with SGLT2 inhibitors being the most preferred drug of choice universally. In contras…